CAS 60113-83-9
:Glucuronídeo de ácido valproico
- 1-(2-propylpentanoate) beta-D-Glucopyranuronic acid
- 1-O-Valproyl-β-<span class="text-smallcaps">D</span>-glucopyranuronic acid
- Dipropylacetate glucuronide
- Valproate glucuronide
- Valproate-β-<span class="text-smallcaps">D</span>-glucuronide
- Valproic acid glucuronide
- Vpa-G
- β-<span class="text-smallcaps">D</span>-Glucopyranuronic acid, 1-(2-propylpentanoate)
- β-D-Glucopyranuronic acid, 1-(2-propylpentanoate)
Valproic acid-acyl-D-glucuronide
CAS:Valproic acid-acyl-D-glucuronide
Pureza:>98%Cor e Forma:White Lyophilised PowderPeso molecular:320.34g/molValproic acid b-D-glucuronide
CAS:Fórmula:C14H24O8Pureza:≥ 95.0%Cor e Forma:White to beige or yellow powderPeso molecular:320.34Valproic Acid-d15 Beta-D-Glucuronide
CAS:Produto ControladoApplications Valproic Acid-d15 β-D-Glucuronide, is the labeled analogue of Valproic Acid β-D-Glucuronide (V094760), a metabolite of Valproic acid.
References Rudy, A., et al.: J. Pharmacol. Exp. Ther., 259, 1133 (1991), Nagai, K., et al.: J. Antimicrob. Chemother., 39, 295 (1997), Yamamura, N., et al.: Drug Metab. Dispos., 27, 724 (1999)Fórmula:C14H9D15O8Cor e Forma:NeatPeso molecular:335.43Valproic Acid beta-D-Glucuronide
CAS:Produto ControladoStability Hygroscopic
Applications A metabolite of Valproic acid.
References Rudy, A., et al.: J. Pharmacol. Exp. Ther., 259, 1133 (1991), Nagai, K., et al.: J. Antimicrob. Chemother., 39, 295 (1997), Yamamura, N., et al.: Drug Metab. Dispos., 27, 724 (1999)Fórmula:C14H24O8Cor e Forma:Off-WhitePeso molecular:320.34Valproic Acid-d6 β-D-Glucuronide
CAS:Produto ControladoStability Hygroscopic
Applications A labelled metabolite of Valproic acid.
References Rudy, A., et al.: J. Pharmacol. Exp. Ther., 259, 1133 (1991), Nagai, K., et al.: J. Antimicrob. Chemother., 39, 295 (1997), Yamamura, N., et al.: Drug Metab. Dispos., 27, 724 (1999)Fórmula:C14H18D6O8Cor e Forma:NeatPeso molecular:326.37Valproic acid b-D-glucuronide
CAS:Produto ControladoValproic acid b-D-glucuronide is a drug that belongs to the group of anticonvulsants. Valproic acid b-D-glucuronide inhibits the activity of glutamate, which is an excitatory neurotransmitter in the brain. It also causes irreversible inhibition of GluCl channels and increases diastolic pressure. Valproic acid b-D-glucuronide has been shown to have anti-inflammatory properties, as it reduces the production of prostaglandins and cytokines. The drug has been used in animal models to study pain perception and chronic pain syndromes such as bone cancer or metabolic disorders. Valproic acid b-D-glucuronide also blocks GABA receptors, causing increased levels of gamma aminobutyric acid (GABA) and dopamine. The drug has been shown to induce a state of deep sleep in rats that are deprived from REM sleep for three weeks.
Fórmula:C14H24O8Pureza:Min. 95%Cor e Forma:PowderPeso molecular:320.34 g/molRef: 3D-MV16889
Produto descontinuado





